Cephalon Can't Fight IP Battle In FTC Pay-For-Delay Suit
A Pennsylvania federal judge ruled Tuesday that Cephalon Inc. cannot make arguments about the strength of a Provigil patent in the Federal Trade Commission's pay-for-delay suit against the drugmaker because of...To view the full article, register now.
Already a subscriber? Click here to view full article